Gene therapy solutions
Highly accurate HiFi sequencing allows researchers to comprehensively discover, design and confirm their gene therapy approaches.
Improve vector design with full-length AAV sequencing
Discover, verify, and improve AAV vector design with full-length, highly accurate AAV sequencing.
Verify expression vectors are expressing desired transcripts
Confirm that gene therapy vectors are expressing the desired transcripts for protein synthesis with full-length isoform sequencing (Iso-Seq method).
- Understand the challenges of AAV sequencing and the unique advantages of using PacBio long reads to address these unmet needs
- Hear how biopharmaceutical researchers are using highly accurate HiFi reads for vector discovery, design, and quality control
- Learn about the PacBio AAV solution and analyses
Benefits of gene therapy and the promise of adeno-associated virus (AAV) vectors
AAV gene therapy can address the underlying genetic problems that cause disease and holds great promise to help improve human health. By increasing our understanding of the genetic components underlying disease, scientists can improve AAV gene therapy and change the course of disease.
PacBio AAV sequencing offers distinct advantage of being able to sequence the entire, intact, ~4.7kb construct with high accuracy. The ability to see full length is important for discovery and for identifying truncated products while high accuracy is important for identifying undesired mutations.
HiFi sequencing advantages in gene therapy
Common questions about gene therapy
1Berns, K. I., & Muzyczka, N. (2017). AAV: An Overview of Unanswered Questions. Human gene therapy, 28(4), 308–313.
2Meier AF, Fraefel C, Seyffert M. The Interplay between Adeno-Associated Virus and Its Helper Viruses. Viruses. 2020; 12(6):662.
High accuracy and complete visibility are critical to the success of novel vector discovery, vector design, and manufacturing quality control for gene therapy products. HiFi sequencing is the ideal solution due to its ability to sequence full-length AAV genomes at high accuracy.
With HiFi, you can
- Sequence the entire AAV molecule to discover novel capsid constructs with the potential to improve tissue-specific delivery1
- Identify structural variants, truncations, chimera, even human host material that can affect the safety and integrity of the therapeutic2
1Reference: Structural characterization of a novel human adeno-associated virus capsid with neurotropic properties (nature.com) NATURE COMMUNICATIONS | (2020) 11:3279 | https://doi.org/10.1038/s41467-020-17047-1 | www.nature.com/naturecommunications.
2Reference: Tai, P.W. et al. (2018) Adeno-associated virus genome population sequencing achieves full vector genome resolution and reveals human-vector chimeras. Molecular Therapy. 9:130–141.
Gene therapy technique in action
Obtain complete information about the quality of vectors in AAV studies
Studying AAV and scaling their production while maintaining vector quality is quickly becoming a major focus for biopharmaceutical companies. Short-read sequencing cannot reveal complete information about the quality of the vector, which can impact the safety or integrity of the product.
Gene therapy validation with single-molecule resolution using highly accurate HiFi reads
Discover how gene editing protocols can benefit from long-read sequencing at multiple stages to optimize and enhance vector integrity.
Highly accurate SMRT sequencing for gene therapy applications
Phillip Tai from the University of Massachusetts Medical School discusses his investigation in the design compatibility of CRISPR-Cas9 components in AAV vectors.
Researchers reveal impurities in AAV packaged genomes with HiFi sequencing — not detectable by short-read sequencing
Advantages of highly accurate HiFi reads for verifying AAV constructs
PacBio’s AAV end-to-end workflow and flexible protocol allow scientists to comprehensively profile packaged genomes as individual intact molecules to identify potential contaminants that can affect the safety, efficacy, and cost-effectiveness of AAV vector gene therapy.
- Discover novel potential capsid constructs
- Conduct vector quality control experiments
- Assess the safety of resulting constructs
Ida Hoijer of Uppsala University shares her research on developing a long-read sequencing-based method for detection of CRISPR-Cas9 off-target effects, along with a customized analysis pipeline.
Researchers discover CRISPR-Cas9 method results in far more genomic changes than previously thought — including big deletions and rearrangements — was made possible by the use of long-read SMRT sequencing.
Using PacBio long-read sequencing, researchers discover heavy rearrangement at integration site which can potentially impact vector integrity and the safety of the gene therapy drug